| IRF2BPL |
Q9H1B7
|
interferon regulatory factor 2 binding protein like
|
|
0.84 |
0.631 |
0.462 |
| ARID1B |
Q8NFD5
|
AT-rich interaction domain 1B
|
|
1.00 |
0.503 |
0.846 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| NPHP3-ACAD11 |
|
NPHP3-ACAD11 readthrough (NMD candidate)
|
|
|
0.663 |
0.577 |
| ANKRD11 |
Q6UB99
|
ankyrin repeat domain 11
|
|
1.00 |
0.556 |
0.808 |
| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| DDX3X |
O00571
|
DEAD-box helicase 3 X-linked
|
|
1.00 |
0.537 |
0.769 |
| ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
| SCN1A-AS1 |
|
SCN1A and SCN9A antisense RNA 1
|
|
|
0.636 |
0.346 |
| FOXG1 |
P55316
|
forkhead box G1
|
|
0.94 |
0.522 |
0.692 |
| TRIP12 |
Q14669
|
thyroid hormone receptor interactor 12
|
|
1.00 |
0.678 |
0.462 |
| HGSNAT |
Q68CP4
|
heparan-alpha-glucosaminide N-acetyltransferase
|
|
6.3E-08 |
0.628 |
0.577 |
| ASXL2 |
Q76L83
|
ASXL transcriptional regulator 2
|
|
1.00 |
0.617 |
0.692 |
| ERCC8 |
Q13216
|
ERCC excision repair 8, CSA ubiquitin ligase complex subunit
|
|
2.8E-15 |
0.551 |
0.885 |
| TRIP11 |
Q15643
|
thyroid hormone receptor interactor 11
|
|
1.7E-12 |
0.595 |
0.654 |
| LZTR1 |
Q8N653
|
leucine zipper like transcription regulator 1
|
|
1.0E-92 |
0.547 |
0.808 |
| KCNMA1-AS1 |
|
KCNMA1 antisense RNA 1
|
|
|
0.705 |
0.654 |
| PUF60 |
Q9UHX1
|
poly(U) binding splicing factor 60
|
|
1.00 |
0.536 |
0.769 |
| MED13L |
Q71F56
|
mediator complex subunit 13L
|
|
1.00 |
0.617 |
0.538 |
| TMCO1 |
Q9UM00
|
transmembrane and coiled-coil domains 1
|
|
9.4E-10 |
0.588 |
0.654 |
| VPS13B |
Q7Z7G8
|
vacuolar protein sorting 13 homolog B
|
|
2.5E-45 |
0.579 |
0.769 |
| LAMA1 |
P25391
|
laminin subunit alpha 1
|
|
3.2E-32 |
0.582 |
0.808 |
| SPG11 |
Q96JI7
|
SPG11 vesicle trafficking associated, spatacsin
|
|
1.6E-39 |
0.576 |
0.538 |
| MITF |
O75030
|
melanocyte inducing transcription factor
|
|
0.98 |
0.499 |
0.808 |
| PRR12 |
Q9ULL5
|
proline rich 12
|
|
1.00 |
0.716 |
0.385 |